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1. Introduction 
The development of atrial remodeling process could contribute to the structural and 
electrophysiological changes in pulmonary veins (PVs) and atrium; which could promote 
local conduction abnormalities and cause an increased the arrhythmogenecity resulting in 
atrial fibrillation (AF) persistency.  The efficacy of treatment strategy to restore sinus rhythm 
such as catheter ablation (CA) might be quite decreased in such cases with advanced atrial 
remodeling, therefore it is crucial to know the information associating with atrial electrical 
and structural remodeling for promoting AF. 
In this study, we attempted to determine the novel factors relating the process of structural 
and electrophysiological remodeling in patients with AF in the inflammatory and 
anatomical views.  
2. Novel index as increased inflammation determining the development of 
atrial remodeling 
2.1 Backgrounds 
The causes and pathogenesis of AF recurrences are multifactorial and are related to technical 
factors and a multitude of clinical factors; some studies have explored the possible role of 
inflammatory mechanisms in the pathogenesis of AF.  The C-reactive protein (CRP) is a 
sensitive maker for reflecting a local or systemic inflammatory response, and some clinical 
studies also support the association of an elevated CRP level and an increase in AF episodes. 
In this study, we examined the association between a pre-existent inflammatory response 
and the recurrence of AF after CA, and clarified the clinical and electrophysiolocgical factors 
related to the CRP elevation.  
2.2 Method 
2.2.1 Study population 
The study population consisted of 257 consecutive patients with drug-refractory episodes of 
AF who underwent radiofrequency catheter ablation.  The patients’ mean age was 61 years, 
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187 (73%) were male, and 77 (30%) had persistent AF defined as recurrent episodes of AF 
lasting more than 3 months. The exclusion criteria was as follows, 1; a left atrial diameter 
(LAD) of more than 55mm, 2; significant valvular disease requiring surgery, 3; an ejection 
fraction of less than 40%, and 4; hypertrophic obstructive cardiomyopathy. All 
antiarrhythmic agents (AAAs) were generally discontinued for at least 3 days before the CA. 
Vaugham-Williams Class I (Ia 47.9%, Ic 60.7%) AAAs was prior medicated in 80.9%, class II 
was 15.2%, class III was 10.5%, and class IV was 12.5%.  
2.2.2 Electrophysiological study and catheter ablation 
Transesophageal echocardiography was performed to exclude any left atrial (LA) thrombi.  
A 10-pole or 20-polar diagnostic catheter was positioned in the CS for pacing and recording.  
A 20-pole catheter was located in the right atrium to cover the area around the tricuspid 
annulus or superior vena cava (SVC). The LA and PVs were accessed by a transseptal 
approach.  We introduced 3 steerable catheters including two spiral curve catheters into the 
left atrium through a single transseptal puncture site. The PVs were mapped with a 
circumferential 10-pole or 20-pole catheter (IBI, Irvine, CA, USA). The surface ECG and 
intracardiac electrograms filtered between 30 to 500 Hz were recorded simultaneously with 
a polygraph (DUO EP Laboratory; Bard Electrophysiology, Lowell, MA, USA). A single 
bolus of 150 IU/kg of heparin was administered after the transseptal puncture and repeated 
to maintain an activated clotting time of >300 seconds.   
We initially performed a PV isolation procedure by using a double circular mapping 
technique during an isopreterenol administration (1-2 µg/min).  We confirmed the success 
of the electrical PV isolation by monitoring the circumferential electrical isolation at the 
antrum level: approximately 1 cm from the ostium of both the right and left PVs.  The 
complete disappearance of the potentials from all 4 PVs was confirmed in all patients.  In 
case of burst-inducible AF after the PV isolation procedure, an additional roof line was 
created.  Then, additional RF energy applications were appropriately applied for any mitral 
isthmus, induced atrial tachycardia circuits and complex fractionated electrical activity. If 
the arrhythmogenic foci were suspected to have originated from a non-PV area, they were 
located by searching with a roving catheter.  
Radiofrequency (RF) energy was delivered for 30 to 60 seconds at each site using an 8mm 
tip catheter (Japan Life Line Co., Ltd., Fantasista, Tokyo, Japan). The RF energy was 
delivered with the power limited to 35 W.  The temperature was limited to 55°C.    
2.2.3 CRP measurement  
The assessment of the CRP level was assessed by a high sensitive radio-immunoassay one 
day before the CA procedure.  The CRP level was classified into 4 quartile levels (Quartile 1; 
<0.02 mg/dl, Quartile 2; 0.03-0.07 mg/dl, Quartile 3; 0.08-0.27 mg/dl, and Quartile 4; 0.28< 
mg/dl). 
2.2.4 The evaluation of cardiac parameters 
We measured the end-systolic LA diameter and the left ventricular parameters with 2D-
echocardiography. LA volume and PV diameter was measured by integrating the volume 
traced in each slice of the 64-slice-MDCT scan (Philips Medicals Systems) one day before the 
CA. 
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2.2.5 Follow-up 
All patients were discharged to home 3 days after the CA procedure and were seen in our 
hospital at 1-2 month intervals. The in-hospital AF episodes were carefully monitored for at 
least 2 days after the CA, and the AF episodes after discharge were adequately assessed by 
the patients’ complaints, 12 lead ECG and 24 hour Holter ECG recordings. AF recurrence 
was defined as the occurrence of atrial tachyarrhythmias after a 2 month blanking period 
following the CA procedure. AAAs were given for 3 to 6 months to the patients with long-
lasting persistent AF or to those with paroxysmal AF and easily induced residual AF. 
Following that, the AAAs were withdrawn and the AF episodes were further assessed 
without AAAs.   
2.3 Result 
2.3.1 CRP level relating clinical, structural, electrophysiological findings 
Table 1 shows the association between the CRP quartiles and clinical characteristics. In 
clinical characteristics, the age, prevalence of structural heart disease, prevalence of 
hypertension, and number of prior anti-arrhythmic agents were significantly increased 
when the CRP level was elevated.   
 
 
Table 1. Patient characteristics  and CRP quartiles 
Table 2 shows the association among the CRP quintiles and structural, 
electrophysiological, procedural findings. In structural findings, the left atrial diameter 
was significantly increased for an elevated CRP level, and the LA volume also tended to 
be increased with a CRP elevation. IN electrophysiological findings, arrrhythmogenisity 
from PVs were significantly decreased when the CRP level was increased. However, the 
atrial substrate after PV delineation to maintain AF were highly observed when the CRP 
level was elevated. 
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Table 2. Structural, electrophysiological and procedural findings and CRP quartiles 
2.3.2 CRP level and clinical course 
Figure 1 represents the relation between the AF occurrence after the CA and the CRP 
quartiles.  AF occurrence after CA was significantly higher when the CRP level was elevated 
(quintile 1; 11%, quintile 2; 13%, quintile 3; 20%, and quintile 4; 30% p<0.001). 
The univariate analysis revealed that the CRP quartile, left atrial diameter, persistent AF, AF 
duration (m), number of prior AAAs, mitral isthmus line and superior vena cava isolation 
were significant factors for an AF recurrence. The multivariate analysis revealed that the CRP 
quartile [Odds ratio (95% CI); 2.06 (1.02-4.22)] was an independent factor to AF recurrences, as 
well as, the left atrial diameter [1.31(1.12-1.52)] and persistent AF[1.09(1.01-1.19)].  
Figure 2 represents the effects of statins on the AF recurrence. The use of statins was 
significantly associated with a decreased incidence of an AF recurrence (7% vs. 19%, 
p<0.05), whereas the use of ACE or AII antagonists was not significantly associated with an 
AF recurrence (16% vs. 16%, p<0.05). 
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Fig. 1. The relation between the AF occurrence after the CA and the CRP quartiles.  
 
 
Fig. 2. The statin use and the AF occurrence after the CA.  
2.3.3 The comparison of parameter and outcome between paroxysmal and persistent 
AF 
CRP level (0.18±0.26 vs. 0.33±0.89 mg/dl, p=0.042) and left atrial diameter (35.1±5.4 vs. 
38.9±5.2, p<0.001) were significantly lower in patients with paroxysmal than persistent AF. 
As procedural findings, the additional roof line creation (64% vs. 95%, p<0.001) and mitral 
isthmus line creation (13% vs. 37%, p=0.038) were significantly lower in patients with 
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paroxysmal than persistent AF. The residual burst pacing inducible AF at the end of CA was 
significantly lower in patients with paroxysmal than persistent AF (14% vs. 36%, p<0.001). 
Figure 3 demonstrated the comparison of AF recurrence between paroxysmal and persistent 
AF. AF recurrence was significantly lower in patients with paroxysmal than persistent AF 
(15 % vs. 24%, p<0.01), although several clinical bias relating to structural remodeling were 
included between both groups.  
 
 
Fig. 3. The comparison of AF recurrence between paroxysmal and persistent AF. 
2.4 Discussion 
2.4.1 Epidemiological significance of inflammation on AF  
Epidemiological studies have demonstrated that during an inflammatory response the CRP 
level is significantly higher in AF patients than in non-AF patients, and the increased CRP 
level is an independent contributing factor for the future development of an AF occurrence 
(Chung et al. 2001).  The concept that inflammation contributes to at least some types of AF 
is supported by the frequent occurrence of AF after cardiac surgery (Bruins et al. 1997), a 
genetic study (Gaudino et al. 2003), and the association of AF with pericarditis (Spodick 
1976). In particular, AF occurrences were highly observed in 5 to 70% of patients after 
cardiac surgery (Hogue et al. 1999); which may explain the clinically significant impact of 
the inflammatory response on AF occurrences, whereas hemodynamic intolerance and 
neuro-hormonal factors may also basically be associated with the development of AF by 
promoting the atrial functional and anatomical remodeling process.       
2.4.2 Inflammation and the AF occurrence after CA 
It has been reported that the electrical reconnection of isolated PV potentials might mainly 
be related to the AF occurrence after CA in patients with paroxysmal AF (Cappato et al. 
2003). However, a PV electrical isolation strategy alone for patients with an enlarged atrium 
or persistent AF might be quite limited.  It is now recognized that the development of AF 
leads to electrical and structural changes within the atria that perpetuate the atrial 
tachyarrhythmia. Shortening of the atrial refractory period and prolongation of the atrial 
conductivity as the result of a remodeled atrium could allow for the promotion and 
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maintenance of multiple wavelet-re-entry circuits. The structural changes, including left 
atrial dilatation, further increase the fibrotic process with deposition of increased amounts of 
connective tissue, and promote the inconsistency and prolongation of the atrial conduction 
which leads to maintaining the perpetuation of AF.  Previous studies have shown that AF 
recurrence after CA is significantly higher in patients with inducible AF after the PV 
isolation than in those without AF (Wright et al. 2008), and a younger age, smaller left atrial 
diameter(Van Gelder et al. 1991), and shorter duration of AF(Wijffels et al. 1995) are 
predictors of sinus rhythm maintenance.  The results of those studies suggest that many of 
the AF recurrences are thought to be secondary to electrical and structural remodeling.  In 
this study, the increased CRP level was significantly associated with an advanced age and 
structural heart disease with a significant relationship to a high AF inducibility after the PV 
isolation during the CA.  Thus, these findings indicate that an increased CRP level might be 
a useful marker for the atrial remodeling process which would promote the future 
development of AF after the CA.  
2.4.3 The mechanism of AF occurrence caused by inflammation 
The precise mechanism for the increased circulating CRP level in AF is uncertain, but might 
reflect the active participation of CRP in the local inflammatory response within the atrial 
myocardium.  In this study, AF recurrence was clearly associated with increased CRP levels 
even after the adjustment for confounding factors; which implies that the CRP may have a 
direct linkage to the AF occurrence, and not only be a secondary marker for atrial 
remodeling.  Historical evidence to support a direct association between AF and 
inflammation can be extracted from the frequent association of AF to inflammatory 
conditions of the heart, such as myocarditis and pericarditis. Transient AF episodes were 
frequently observed after open heart surgery, and the results of the atrial biopsies taken 
from patients in AF have demonstrated evidence of inflammatory infiltration within the 
atrial tissue (Frustaci et al. 1997).  The CRP could possibly bind to the membranes of the 
myocardial cells in inflamed tissues, and release an activating complement, leading to tissue 
damage.  Data from ischemic heart disease also supporting the deposits of CRP, have also 
been demonstrated on immunohistochemical staining, in the vascular wall of active 
atherosclerotic plaques, where it is co-localized with the complement complex (Lagrand et 
al. 1997).  Moreover, CRP has been shown to act as an opsonin and may participate in the 
clearance of apoptotic myocyte loss (Mevorach 2000).  Myocyte loss is typically accompanied 
by replacement fibrosis.  Thus, that local inflammatory response in the atrium may also be a 
part of the structural remodeling process associated with an increased occurrence of AF. 
2.4.4 Anti-inflammatory agents for preventing AF occurrences 
Recently studies have shown that the use of anti-inflammatory agents is associated with a 
decreased incidence of AF. The capacity of statins to reduce inflammation, CRP levels and 
oxidative stress is well-established (Strandberg et al. 1999) (Plenge et al. 2002).   In a 
retrospective study, statins decreased the recurrence after successful external cardioversion 
of persistent lone AF (Siu et al. 2003); in a prospective analysis, statins protected against 
atrial fibrillation in patients with stable coronary artery disease (Young-Xu et al. 2003).  The 
use of statins has recently been related to a 3-fold decrease in the odds of AF after 
noncardiac thoracic surgery (Amar et al. 2005), and has a lower incidence of AF (Marin et al. 
2006) or other cardiac arrhythmias (Dotani et al. 2000) after coronary artery bypass surgery.  
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Pretreatment with statins, which significantly reduces the inflammatory cytokines and 
prevents the adhesion between the inflammatory cells and endocardium, is likely to 
facilitate the prevention of inflammatory mediated AF episodes.  
There is evidence suggesting an association between AF and an enhanced renin angiotensin 
system activity. Experimental studies have revealed that angiotensin II possesses several pro-
inflammatory properties which is the key mediatory factor in the inflammatory cascade 
(Healey et al. 2005).  Further, angiotensin II exhibits a growth-enhancing effect on cardiac 
myocytes as well as on vascular smooth muscle cells and fibroblasts, thus resulting in the 
remodeling and fibrosis of the atria that could serve as a potential arrhythmogenic substrate 
for the development of AF.  ACE-Is or angiotensin II antagonists have been shown to decrease 
the inflammatory response. (Brull, Sanders et al. 2002) (Hernandez-Presa et al. 1997), and 
prevent the development of myocardial fibrosis related to the electrical and structural 
remodeling process (Nakashima, Kumagai et al. 2000) (Fortuno et al. 1998) (Lopez et al. 2001).   
In the data from this study, the patients with a pre-statin treatment experienced a significant 
decrease in AF episodes after the CA, however the patients with a pre-ACE-I or AII 
antagonist treatment did not experience that beneficial effect.  The patients medicated with 
statins tended to include younger patients, whereas those medicated with ACE-Is or AII 
antagonists tended to include older patients with hypertension or a reduced ventricular 
function; which may have modified the results of the analysis of our data.   
Recent clinical studies have demonstrated that the CRP level is transiently elevated after CA 
(Marcus et al. 2008), and that the short-term AF episodes were transiently increased (Oral et 
al. 2002).  These reports also suggested that the increased inflammatory response from the 
CA procedure may increase the following transient occurrences of AF. Pretreatment with 
statins significantly improved the short-term outcome within 3 days, and not only the long-
term outcome after the CA in this study; which may be expected to facilitate a reduction in 
the AF occurrences after CA and improve the symptoms due to tachyarrhythmias with the 
avoidance of any unnecessary second CA procedures.  Further studies are required to 
examine the beneficial effect of anti-inflammatory agents on improving the short and long 
term outcome after CA. 
3. Novel index as left atrial roof shape determining the development of atrial 
remodeling 
3.1 Backgrounds 
The preexistent morphology of the PVs could modify their arrhythmogenicity (Lin et al. 
2000; Lee et al. 2005; Pak et al. 2006). The development of the remodeling process could 
contribute to the structural and electrophysiological changes in the PVs and atrium; which 
could promote local conduction abnormalities and cause an increased PV/non-PV 
arrhythmogenecity resulting in AF persistency (Lee et al. 2005) (Wijffels et al. 1995) (Hoit et 
al. 1998) (Chen et al. 2002) (Johnson et al. 1986).  This evidence supports the observation that 
the morphological findings of the PVs and atrium may include a crucial role of helping to 
identify the characteristics of their pre-existing arrhythmogenicity (Kurotobi et al. 2011). 
However, there is a methodological limitation of the PVs and atrium in order to evaluate the 
morphological characteristics in a quantitative manner because of their own unique, 
variable and asymmetrical features. 
The part of the left atrial (LA) roof which consists of the upper wall of the left atrium and 
upper PVs, incorporating the LA, was described as the LA roof silhouette, and could easily 
be visualized by pulmonary angiography or CT imaging. The morphological findings of the 
PVs and atrium may include a crucial role of helping to identify the characteristics for the 
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electrical and structural remodelling. In this study, we examined the hypothesis that the LA 
roof shape could be used as a novel predictor in patients with AF to allow us to determine 
the characteristics of the PVs, atrial arrhythmogenicity and substrate for promoting AF. 
3.2 Methods 
3.2.1 Study population 
The study population consisted of 153 consecutive patients with drug-refractory episodes of 
AF who underwent radiofrequency catheter ablation (CA).  The patients’ mean age was 62 
years, 122 (80%) were male, and 58 (38%) had persistent AF defined as recurrent episodes of 
AF lasting more than 3 months. The exclusion criteria was same as CRP study.  
3.2.2 Electrophysiological study and catheter ablation 
Electrophysiological study and ablation procedure was same as CRP study, and had already 
stated in the section of 2.2.2. 
3.2.3 The induction and detection of the arrhythmogenic foci 
The induction of arrhythmogenic foci was performed according to our previously reported 
paper (Kurotobi, Iwakura et al.). In brief, spontaneous arrhythmogenic foci in both atria 
were induced and carefully mapped before and after the PV isolation procedure using an 
intravenous infusion of high dose isoproterenol (ISP) of up to 20 µg/min without any 
sedation. If AF persisted or spontaneously occurred under the ISP, we attempted to 
cardiovert the AF up to 3 times. To detect the location of the arrhythmogenic foci, we 
simultaneously used five multipolar catheters to record the electrograms from the PVs and 
outside the PVs to search for any arrhythmogenic foci.  A 20-pole catheter (2 mm inter-
electrode spacing) covered the area from the SVC to the crista terminalis, coronary sinus, 
and ostium of the left PVs. A roving catheter was located at the right superior PV ostium.  
During the ablation procedure, the ISP administration was maintained at 1-2 µg/min. At the 
end of the procedure, the same induction maneuvers as in the initial protocol (up to 20 
µg/min) were repeated. Arrhythmogenic foci were defined as direct AF triggers or 
spontaneous reproducible atrial premature beats with coupling intervals of < 350ms or 
frequent repetitive firings.  
3.2.4 The evaluation of left atrial volume 
We measured the end-systolic LA diameter and left ventricular parameters with 2D-
echocardiography. The LA volume and PV diameter were measured by integrating the 
volume traced in each slice of the 64-slice-MDCT scan (Philips Medicals Systems) during 
several days prior to the CA. To enhance the cardiac cavity, contrast medium was injected at 
a flow-rate of 2.5 mL/s through an antecubital vein using an injector. The LA volume was 
measured by integrating the volume traced in each slice of the CT scan from the level of the 
mitral annulus to the roof of the left atrium with commercially available software (EP 
planner, Philips Medical Systems, Haifa, Israel). Each slice was automatically traced with 
digital markers to exclude the PVs and LA appendage at their ostial level. The LA 
appendage was excluded from the volumetric analysis. 
3.2.5 The assessment of the LA roof shape  
According to the PVs and LA dominant level, we classified the LA roof shape into a deep V 
shape (group A; Possible PV dominant type), shallow V shape (group B) and flat-coved 
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shape (group C; Possible LA dominant type) using both PVs cine angiography (Figure 4). 
Cine angiography was performed by spontaneous contrast medium injection from the long 
sheath located at the upper right and left PVs. The shape of LA roof was determined by 
using antero-posterior projection, and was assessed by an upper angle between the right 
and left side LA wall silhouette. Deep V shape (A) was defined an less than 140°, shallow, V 
shape (B) was 140°,-180°, and flat-coved shape was more than 180°(C).  
 
 
Fig. 4. Classification of roof shape. 
3.3 Results 
3.3.1 Patient characteristics and roof shape 
The comparison of the patient characteristics among group A, B and C are shown in Table 3. 
Group A was observed in 35 patients (23%), B in 76 (50%), and C in 42 patients (27%). There 
were no significant differences in the mean age, mean AF duration, or clinical coexistence of 
atrial flutter, among the 3 groups. As the LA roof silhouette became flat, the number of prior 
of AAD’s (A; 2.1±0.9 vs. B; 1.7±1.4 vs. C; 1.2±0.8, p=0.003) significantly decreased, and the 
prevalence of structural heart disease (A; 19% vs. B; 40% vs. C; 68%, p=0.002) and persistent 
AF (A; 26% vs. B; 35% vs. C; 52%, p=0.014) significantly increased. 
 
 
Table 3. Clinical background and roof shape 
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3.3.2 Relationship among the LA roof shapes and electrophysiological and structural 
findings 
The electrophysiological and structural findings of each roof shape group are shown in 
Table 4.  
As the LA roof silhouette became flat, the incidence of AF arising from the PVs (A; 70% vs. 
B; 57% vs.C; 40%, p=0.003), AF from the upper PVs (A; 63% vs. B; 41% vs. C; 38%, p=0.046) 
and from arrhythmogenic foci including reproducible premature beats (A; 94% vs. B; 84% 
vs. C; 76%, p=0.033) significantly decreased. On the other hand, the incidence of AF arising 
from non-PV sites (A; 6% vs. B; 13% vs. C; 22%, p=0.041) and from arrhythmogenic foci from 
non-PV sites (A; 26% vs. B; 46% vs. C; 54%, p=0.016) significantly increased as the LA roof 
silhouette became flat. A multivariate analysis demonstrated that the deep V shape was an 
independent contributing factor to AF triggers from PV [Odds ratio (95% CI); 2.94 (1.27-
6.80), p=0.012]. As the LA roof silhouette became flat, the incidence of pacing inducible AF 
just after the PV isolation (A; 51% vs. B; 65% vs. C; 79%, p=0.001) and at the end of the CA 
(A; 12% vs. B; 24% vs. C; 36%, p=0.016) significantly increased. 
The LA diameter (A-P; 33.1±2.8 mm for A vs. 37.4±5.6mm for B vs. 40.2±6.3mm for C, 
p<0.001;. S-L; 36.1±5.8 mm for A vs. 39.4±6.6 mm for B vs. 43.2±6.8 mm for C, p<0.001; MV-
PV; 48.2±6.0 mm for A vs. 55.3±8.7 mm for B vs. 58.4±7.6 mm for C, p<0.001.) and entire LA 
volume (A; 69.5±24.1 ml vs. B; 85.2±34.9ml vs. C; 105.7±45.4, p<0.001) became significantly 
larger, as the LA silhouette became flat. The PV diameter of each PV and left ventricular 
ejection fraction did not differ between the three roof shape groups. 
 
 
Table 4. Relation between the LA roof shapes and electrophysiological and strictural findings 
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3.3.3 Clinical outcome 
An in-hospital recurrence was observed in 28/152 (18%) patients, and a long-term AF 
recurrence was observed in 29/152 (19%) patients. The mean follow-up period after the CA 
was 567 days (360-1065 days). The AADs were used were administrated after the CA in 30% 
of the patients (persistent; 47%, paroxysmal; 23%). The ratio of additional LA roof line (A; 
64% vs. B; 84% vs. C; 88%, p<0.05), and mitral isthmus line (A; 14% vs. B; 22% vs. C; 34%, 
p<0.05) during CA were significantly highly required as the LA silhouette became flat, 
whereas the AF recurrence was not significantly different among three groups (A; 18% vs. B; 
18% vs. C; 23%, n.s.) . 
3.4 Discussion 
3.4.1 LA roof shape and PV/LA dominancy 
From the embryological view, the PV trunks are shown to derive from a common vessel, 
which becomes absorbed within the LA from superior-posterior direction. This 
incorporation transforms the branches of this common PV into separately inserting 
individual 4 PV trunks, first into the right and left PV trunks and subsequently into the 
superior and inferior trunks (DeRuiter et al. 1995) (Neill 1956) (Yamane et al. 2008). 
Anatomical PV structure could be caused by either anomalous branching of the common PV 
or by the variable absorption level of the common PV into the LA, therefore the 
incorporation level could mainly determine the LA roof shape according to the PV/LA 
dominancy level. When the common PV was incorporated into LA with a greater 
dominancy PVs, the silhouette of LA roof could be expressed by the upper wall of superior 
PVs; which the roof shape may be expressing as a V. On the other side, that was 
incorporated into LA with a less dominancy PVs, the silhouette of LA roof could be mainly 
expressed by the existent upper LA wall; which the LA roof may tend to be a flat shape.  
In this study, an enlarged LA volume has a significant association with flat or coved LA roof 
shape. The development of the atrial structural remodeling process may also change the LA 
roof shape. Vertical LA enlargement could modify LA roof shape and sometimes overlap 
the PV silhouette as a component of LA roof, because the location of PVs is strictly stick to 
right and left lungs. Horizontal LA enlargement may promote the development of flat LA 
roof. Moreover, the advancement of cardiac rotation as a result of aging or hypertensive 
change; which is possibly related to atrial remodeling process, may also change the LA roof 
silhouette.   
3.4.2 LA roof shape and PV arrhythmogenicity 
AF is mainly initiated by PV triggers (Haissaguerre et al. 1998), and a rapidly firing source 
located within the PVs could be responsible for initiating, and in some cases, maintaining 
arrhythmias in patients with AF. The mechanism underlying such rapid discharges from 
PVs, including enhanced automaticity or triggered activity mechanisms may be involved in 
the initiation of AF (Patterson et al. 2005). In this study, AF triggers from PVs were highly 
observed in the patients with a deep V LA roof shape and PV dominancy. A previous paper 
reported that AF tended to originate from larger pulmonary veins (PVs) (Yamane et al. 
2002). Especially in the superior PVs, the enlargement may often be consistent with the site 
of the arrhythmogenic PVs (Lin et al. 2000). PV enlargement caused by the stretch 
mechanism may increase the PV’s automaticity and/or triggered activity to initiate AF 
(Satoh and Zipes 1996). However, there was no significant relation between the LA roof 
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shape and PV diameter in this study. These findings may imply the novelty and 
independence of the LA roof shape as an index of the PV’s arrhythmogenicity, as compared 
with the prior reports which discussed the PV features. 
3.4.3 LA roof shape and non PV arrhythmogenicity 
Non-PV foci could arise from the superior vena cava, left atrial posterior free wall, crista 
terminalis, ostium of the coronary sinus, inter atrial septum, or Marshall bundle (Hwang, 
Wu et al. 2000) (Chen et al. 1999) with an incidence of those ranging from 3.2 to 47% (Lin et 
al. 2003) (Mangrum et al. 2002) (Schmitt et al. 2002). The predominant non-PV triggering 
sites have a slow diastolic depolarization that enhances spontaneous depolarization (Chen 
et al. 2002), and the triggered activity of the non-PV triggers could also be involved in the 
onset and perpetuation of AF.. 
Because triggered activity is likely to occur in the presence of underlying disease such as 
cardiomyopathy (Boyden et al. 1984), the development of the atrial remodeling process may 
enhance the triggered activity of non PV lesions. A previous study reported that multiple 
PV arrhythmogenic foci may be associated with an older age, longer AF duration, and larger 
atrial all triggers (Lee et al. 2005), and persistent AF is more frequently triggered by foci 
from the LA side of the LA–PV junction than is paroxysmal AF(Pak et al. 2006). These 
findings could explain why the flat and cove LA roof as a result of advanced atrial 
remodeling increased the non PV arrhythmogenisity in this study.  
3.4.4 The significance of LA roof shape as ablation strategy 
It is now recognized that the development of AF leads to electrical and structural changes 
within the atria that perpetuate the atrial tachyarrhythmia. The structural changes, including 
the enlarged LA, further promote the inconsistency and prolongation of the atrial 
conduction which leads to maintaining the perpetuation of AF.  In this study, the incidence 
of pacing inducible AF just after PV isolation and at the end of the CA significantly 
increased, as the LA roof silhouette became flat. A previous paper reported that AF 
recurrence after CA was significantly higher in patients with inducible AF after the PV 
isolation than in those without AF (Wright et al. 2008), therefore that evidence indicates the 
importance of a flat or coved LA roof shape as a reflection of any latent AF substrate in the 
atrium. And also, the development of the atrial remodeling process could enhance the 
triggered activity of non-PV lesions(Lee et al. 2005) (Boyden et al. 1984). In this study, non-
PV foci were significantly more often observed in patients with a flat-coved LA roof shape.  
P V isolation is the cornerstone of the treatment especially in patients with paroxysmal AF, 
however the PV electrical isolation strategy alone in patients with a remodeled atrium might 
be quite limited.  Many of the AF recurrences are thought to be secondary to electrical and 
structural remodeling (Wijffels et al. 1995) (Van Gelder et al. 1991). Thus, a further 
additional extensive intervention following the PV isolation might be required to improve 
the outcome of the CA in patients with a flat-coved LA roof, whereas only a PV isolation 
strategy could lead to a favorable outcome in patients with a deep V LA roof. 
4. Conclusion 
Pre-exsistent CRP level and the shape of the LA roof shape as novel factors allowed us to 
understand the structural and the electrophysiological information of the pulmonary vein 
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and atrium. This information is useful for determining the appropriate strategy for the CA 
of AF.  
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